TRVI — Trevi Therapeutics Inc · $2.32B cap

Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.

Use this TRVI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TRVI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TRVI SEC filings page. Lician reads the product cache first so this HTML stays unique to Trevi Therapeutics Inc even when a live quote feed is slow.

Trevi Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full TRVI income, balance, and cash tables.

  • Revenue$0
  • Net Income-$42.8M
  • Total Assets$193.4M
  • Total Debt$0
  • Free Cash Flow-$42.1M